-
Signature
-
/s/ Lisa Lenstrohm, Attorney-in-Fact
-
Stock symbol
-
IBEX
-
Transactions as of
-
Dec 31, 2022
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
6/30/2023, 05:45 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
IBEX |
Common Shares |
|
|
|
|
|
27.8K |
Dec 31, 2022 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| holding |
IBEX |
Stock Option (Right to Buy Common Shares) |
|
|
|
|
|
|
Dec 31, 2022 |
Common Shares |
10K |
$12.75 |
Direct |
F1 |
| holding |
IBEX |
Stock Option (Right to Buy Common Shares) |
|
|
|
|
|
|
Dec 31, 2022 |
Common Shares |
8.11K |
$19.00 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The Company determined that as of December 31, 2022, the Company no longer qualified as a foreign private issuer. Beginning July 1, 2023, the Reporting Person is subject to Section 16 of the Securities Exchange Act of 1934. Exhibit 24 - Power of Attorney